Prof. Dr. Mutlu DemirayMedical Oncology

Dr. Ashkan Adibi

Cancer Genetics Specialist

By decoding the molecular ciphers of cancer, we turn complex cellular-level data directly into life-saving strategies. For us, a comprehensive genomic profile is not merely a test result but a patient-specific survival map, shaped by the collective intelligence of clinicians, researchers, and diagnostic specialists. Our core mission is to reduce to zero the distance between the latest discoveries in the laboratory and the patient's bedside.

To this end, we analyze multi-omic data for Molecular Tumor Boards (MTBs), detect drug-resistance mechanisms at the cellular level, and design the most optimized targeted therapies. We bring our vision of turning personalized oncology into standard clinical practice to life through strong bridges built with the world's leading genomic companies and global academic consortia. We do not merely treat today's patients; through our translational research, international training programs, and mentorship vision, we also help shape the future of oncology.

Dr. Ashkan Adibi

Professional career

2022 – Present
Cancer Genetics Specialist
Medicana Health Group, Personalized Cancer Treatment Center
2017 – 2019
Supervisor · Hematology, Blood Bank and Biochemistry Departments
Tabriz Sina, Iran
2014 – 2017
Assistant · Teaching of Molecular Techniques
Tabriz International Hospital Research Center, Iran
2010 – 2013
Assistant · Genetics and Medical Laboratory
Provincial Central Laboratory, Tabriz, Iran
2010 – 2012
Laboratory Science Specialist · Cytogenetics and Medical Laboratory
Dr. Salehi Laboratory, Tabriz, Iran

Academic career

2020 – 2025
PhD · Cancer Genetics
İstanbul University, Institute of Oncology
2013 – 2016
MSc · Genetics
Tehran Science and Research University, Iran
2008 – 2013
BSc · Medical Laboratory Sciences
Tabriz Azad University of Medical Sciences, Iran

Areas of work

Scientific publications

International network